Directory of funded grants

Filter by

774 results found

Targeting KCC2 for rescuing functional impairments in Alzheimer’s disease

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer’s Association International Grant Program

  • Province

    Québec

  • Start Date

    2024

  • Total Grant Amount

    $200,000

  • Health Canada Contribution

    $100,000

Project Overview

Background Within the brain, cells communicate by sending signals that either enhance or dampen the activity of other cells. Balancing these excitatory and inhibitory signals is vital for the brain to function. Many components maintain this balance, but one key player is the protein KCC2. As levels of KCC2 are…

Self-disclosure about dementia on social media: evidence-informed guidance

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer’s Association International Grant Program

  • Province

    British Columbia

  • Start Date

    2023

  • Total Grant Amount

    $149,666

  • Health Canada Contribution

    $68,031

Project Overview

Individuals who engage on social media often disclose a personal dementia diagnosis or identify as a caregiver, yet little is known about the impact of that disclosure. The goal of this project is to address this gap and develop a resource to support users to navigate social media. We will…

A Drug Screening Assay to Reduce LINGO-1 Amounts in Neurons

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer’s Association International Grant Program

  • Province

    Québec

  • Start Date

    2022

  • Total Grant Amount

    $150,000

  • Health Canada Contribution

    $75,000

Project Overview

The LINGO-1 protein is strongly associated with Alzheimer’s disease and is a novel drug target. LINGO-1 is a transmembrane protein that negatively regulates neuronal survival and myelination. LINGO-1 inhibition increases survival of multiple neural types and improves spatial learning, memory, and cognitive abilities in multiple mouse models. Thus, we hypothesize…

Cognitive training platform to revolutionize healthcare for people with concussions

  • Grant Type

    Platform grants

  • Area of research

    Injury

  • Disease Area

    Brain Injury

  • Competition

    CQDM - Brain Canada - Quantum Leap

  • Province

    Québec

  • Start Date

    2024

  • Total Grant Amount

    $2,100,000

  • Health Canada Contribution

    $771,500

Project Overview

Led by Dr. Jocelyn Faubert from the Université de Montréal in collaboration with Neurotracker Athletics Inc., this project includes an inter-provincial research collaboration with Prof. Brian Christie and Prof. Jodie Gawryluk from the University of Victoria. Awarded through the CQDM-Brain Canada Joint Call for Collaborative Research Projects on the Brain…

A novel immunotherapy based on genetically modified hematopoietic stem cells as a new hope for treating glioblastoma, an aggressive cancerous tumor of the brain

  • Grant Type

    Platform grants

  • Area of research

    Cancer

  • Disease Area

    Brain Cancer

  • Competition

    CQDM - Brain Canada - Quantum Leap

  • Province

    Québec

  • Start Date

    2024

  • Total Grant Amount

    $2,500,000

  • Health Canada Contribution

    $1,000,000

Project Overview

Led by Dr. Elie Haddad from CHU Sainte-Justine in collaboration with Immugenia, this project includes an inter-provincial research collaboration with Prof. Scott McComb and Prof. Anna Jezierski of the National Research Council of Canada (NRC) and the University of Ottawa who are advancing research innovations through the NRC’s Disruptive Technology…